Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis

Fig. 3

Publication bias and sensitivity analysis. A Detection of publication bias; a funnel plot; b Egger’s test; B sensitivity analysis of overall survival, progression-free survival, and objective response rate. a Nivolumab monotherapy versus chemotherapy in OS; b Nivolumab monotherapy versus chemotherapy in PFS; c Nivolumab monotherapy versus chemotherapy in ORR

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us